Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 216

The DOI matches its Crossref record.

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Open access
Lapteva, Natalia, Durett, April G., Sun, Jiali, Rollins, Lisa A., Huye, Leslie L., Fang, Jian, Dandekar, Varada, Mei, Zhuyong, Jackson, Kimberley, Vera, Juan, Ando, Jun, Ngo, Minhtran C., Coustan-Smith, Elaine, Campana, Dario, Szmania, Susann, Garg, Tarun, Moreno-Bost, Amberly, Vanrhee, Frits, Gee, Adrian P., Rooney, Cliona M. · 2012 · Cytotherapy

Abstract

Background aims Interest in natural killer (NK) cell-based immunotherapy has resurged since new protocols for the purification and expansion of large numbers of clinical-grade cells have become available. Methods We have successfully adapted a previously described NK expansion method that uses K562 cells expressing interleukin (IL)-15 and 4-1 BB Ligand (BBL) (K562-mb15-41BBL) to grow NK cells in novel gas-permeable static cell culture flasks (G-Rex). Results Using this system we produced up to 19 × 109 functional NK cells from unseparated apheresis products, starting with 15 × 107 CD3− CD56+ NK cells, within 8–10 days of culture. The G-Rex yielded a higher fold expansion of NK cells than conventional gas-permeable bags and required no cell manipulation or feeding during the culture period. We also showed that K562-mb15-41BBL cells up-regulated surface HLA class I antigen expression upon stimulation with the supernatants from NK cultures and stimulated alloreactive CD8+ T cells within the NK cultures. However, these CD3+ T cells could be removed successfully using the CliniMACS system. We describe our optimized NK cell cryopreservation method and show that the NK cells are viable and functional even after 12 months of cryopreservation. Conclusions We have successfully developed a static culture protocol for large-scale expansion of NK cells in the gas permeable G-Rex system under good manufacturing practice (GMP) conditions. This strategy is currently being used to produce NK cells for cancer immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/14653249.2012.700767

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 216

Metadata

Authors
Lapteva, N., Durett, A. G., Sun, J., Rollins, L. A., Huye, L. L., Fang, J., Dandekar, V., Mei, Z., Jackson, K., Vera, J., Ando, J., Ngo, M. C., Coustan-Smith, E., Campana, D., Szmania, S., Garg, T., Moreno-Bost, A., Vanrhee, F., Gee, A. P., & Rooney, C. M.
Venue
Cytotherapy
Publisher
Elsevier BV
Published
2012-09
Volume
14
Issue
9
Pages
1131-1143
ISSN
1465-3249 (ISSN-L)
OpenAlex
W2148239543
Cited by
216
References
0
FWCI
5.42
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. https://app.cochat.ai/papers/10.3109/14653249.2012.700767
The paper
Lapteva, N., Durett, A. G., Sun, J., Rollins, L. A., Huye, L. L., Fang, J., Dandekar, V., Mei, Z., Jackson, K., Vera, J., Ando, J., Ngo, M. C., Coustan-Smith, E., Campana, D., Szmania, S., Garg, T., Moreno-Bost, A., Vanrhee, F., Gee, A. P., & Rooney, C. M. (2012). Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy. https://doi.org/10.3109/14653249.2012.700767

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.